Knox Lane

News, insights, analysis and data

Knox Lane overview

Knox Lane contact information

Offices

marker icon655 Montgomery Street, San Francisco, 94111, United States
Showing 1 of 1 Knox Lane offices

Contacts

NameJob titleLocationEmail
Key Contact
user imageMr. Ryan Buntain
Job titleHead of Investor Relations
LocationSan Francisco, United States
Emaillock image-----------
user imageMr. Ivor Van Esch
Job titleChief Financial Officer and Chief Compliance Officer
LocationSan Francisco, United States
Emaillock image-----
user imageMr. John Bailey
Job titleManaging Partner and Founder
LocationSan Francisco, United States
Emaillock image---------
user imageMr. David Coghlan
Job titleManaging Director, Investment
LocationSan Francisco, United States
Emaillock image------

Knox Lane funds managed

Funds in market: 5

FundFund sizeOpen dateStrategy
Fund sizelock image-------
Open dateSep 2026
Strategylock image-----
Fund sizelock image---------
Open dateMay 2025
Strategylock image-----
Fund sizelock image------
Open dateFeb 2025
Strategylock image----------

Closed funds: 3

FundFund sizeClose dateStrategy
Fund sizelock image-----
Close dateJul 2024
Strategylock image----------
Fund sizelock image---------
Close dateMay 2021
Strategylock image------
Fund sizelock image---------
Close date-
Strategylock image------

Stories that mention Knox Lane

Medical education gap presents an opportunity for private equity

The pressing need for more healthcare professionals globally is proving a tailwind for PE investors in medical education.

Texas TRS makes five new commitments to private equity

The Austin-based pension fund committed a total of $270m.

Side Letter: PE's first-timers; Listed PE performers; Secondaries law survey

First-time fundraising isn't likely to get much easier in the near-term, but there are silver linings for those willing to put in the work. Plus: A new index seeks to chart the performance of private equity's listed players; and Secondaries Investor's latest law survey shows a strategy in rude health. Here's today's brief, for our valued subscribers only.